紅寶麗(002165.SZ):第一期員工持股計劃存續期展期
格隆匯6月7日丨紅寶麗(002165.SZ)公佈,公司於2021年6月7 日召開了第九屆董事會第十三次會議,審議通過了《公司關於第一期員工持股計劃存續期展期的議案》,同意公司第一期員工持股計劃存續期展期12個月,即延期至2022年6月8日。
2020 年8 月3 日-8 月7 日,公司員工持股計劃依據相關規定減持公司股份602萬股,佔公司總股本的1%。此後,員工持股計劃未有減持情況,截止2021年6月7日,公司員工持股計劃仍持有公司股份451.5萬股,佔公司總股本的0.75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.